Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Survival Tree01:19

Survival Tree

Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a survival tree begins...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Censoring Survival Data01:09

Censoring Survival Data

Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different reasons...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatially identifying regions of tumor recurrence in patients with suspected recurrent glioma using physiologic MRI and machine learning.

NPJ digital medicine·2026
Same author

MRI Deep Learning for Differentiating Glioblastoma, IDH Wild-type from Central Nervous System Diffuse Large B-cell Lymphoma.

Cancer research communications·2026
Same author

A Genomically Tailored Multiagent Precision Medicine Clinical Trial for Adults with Recurrent Glioblastoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

A cytokine-based serum proteomic score is a prognostic biomarker for immunotherapy in head and neck cancer.

Cancer immunology, immunotherapy : CII·2025
Same author

A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group.

The Lancet. Oncology·2025
Same author

Leveraging quantum chemical properties in transfer learning for predicting blood-brain barrier permeability of drugs.

Drug delivery and translational research·2025

Related Experiment Video

Updated: May 23, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

A partitioning deletion/substitution/addition algorithm for creating survival risk groups.

Karen Lostritto1, Robert L Strawderman, Annette M Molinaro

  • 1Division of Biostatistics, Yale University Schools of Public Health and Medicine, New Haven, CT 06519, USA.

Biometrics
|April 24, 2012
PubMed
Summary
This summary is machine-generated.

This study introduces new methods for the partitioning Deletion/Substitution/Addition (partDSA) algorithm to improve patient risk stratification with censored outcome data. These enhanced partDSA techniques offer more accurate predictions for cancer patients in clinical trials.

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Related Experiment Videos

Last Updated: May 23, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Area of Science:

  • * Biostatistics
  • * Machine Learning in Medicine
  • * Clinical Trial Analysis

Background:

  • * Accurate patient risk assessment is crucial for informed treatment decisions.
  • * Recursive partitioning methods, like Classification and Regression Trees (CART) and partitioning Deletion/Substitution/Addition (partDSA), are used for risk stratification.
  • * Existing methods face challenges with censored outcome data.

Purpose of the Study:

  • * To extend the partDSA algorithm for handling right-censored outcome data.
  • * To develop and evaluate novel loss functions for partDSA using inverse probability of censoring weights.
  • * To compare the performance of the new partDSA extensions against existing methods.

Main Methods:

  • * Development of two extensions for the partDSA algorithm to accommodate censored data.
  • * Utilization of observed data loss functions based on inverse probability of censoring weights.
  • * Evaluation through simulation studies and analysis of brain cancer clinical trial data.

Main Results:

  • * The proposed partDSA extensions demonstrate effective handling of censored outcome data.
  • * Simulation studies indicate the reliability of the new loss functions when censoring models are correctly specified.
  • * The methods were successfully applied to real-world clinical trial data.

Conclusions:

  • * The enhanced partDSA algorithm provides a robust approach for risk stratification with censored data.
  • * These methods improve upon existing techniques for analyzing outcomes in clinical research.
  • * The partDSA package is publicly available in R for broader application.